Lite Strategy (LITS) FCF Margin (2016 - 2023)
Lite Strategy (LITS) posted FCF Margin of 28.33% for Q3 2023, up 96.36% on a QoQ basis from 778.11% in Q2 2023, and up 14172.0% year-over-year from N/an in Q3 2022.
Analysis
Lite Strategy (LITS) FCF Margin (2016 - 2023) Analysis & Trends
Lite Strategy has reported FCF Margin for 8 years, with the latest figure at 28.33% in Q3 2023.
- On a quarterly basis, FCF Margin rose 14172.0% year-over-year to 28.33% in Q3 2023; TTM through Jun 2024 was 77.31%, a 3028.0% increase from a year earlier, with the FY2024 full-year figure at 77.31%, up 3028.0% from the prior year.
- FCF Margin was 28.33% for Q3 2023 at Lite Strategy, up from 778.11% in the prior quarter.
- The five-year high for FCF Margin was 270.56% in Q2 2020, with the low at 1216.77% in Q3 2019.
- Average FCF Margin over 5 years is 351.28%, with a median of 170.05% recorded in 2022.
- The largest YoY upside for FCF Margin was 140946 bps in 2019 against a maximum downside of 117638 bps in 2019.
- Over 5 years, FCF Margin stood at 1039.78% in 2019, then soared by 103 bps to 31.71% in 2020, then sank by 330 bps to 72.83% in 2021, then surged by 40 bps to 43.4% in 2022, then jumped by 35 bps to 28.33% in 2023.
- The last three FCF Margin figures came in at 28.33% (Q3 2023), 778.11% (Q2 2023), and 205.8% (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 14.91% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -18,629.40% |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -28.33% |
| Jun 30, 2023 | -778.11% |
| Mar 31, 2023 | -205.80% |
| Dec 31, 2022 | -43.40% |
| Sep 30, 2022 | -170.05% |
| Jun 30, 2022 | -138.51% |
| Mar 31, 2022 | -176.08% |
| Dec 31, 2021 | -72.83% |
| Sep 30, 2021 | -99.64% |
| Jun 30, 2021 | -151.13% |
| Mar 31, 2021 | -192.95% |
| Dec 31, 2020 | 31.71% |
| Sep 30, 2020 | -146.96% |
| Jun 30, 2020 | 270.56% |
| Mar 31, 2020 | -890.27% |
| Dec 31, 2019 | -1,039.78% |
| Sep 30, 2019 | -1,216.77% |
| Jun 30, 2019 | -715.15% |
| Mar 31, 2019 | -910.89% |
| Dec 31, 2018 | 136.60% |